Partners & Licensees

An engine for discovery

Over 20 partnered programs being developed by our NAV Technology Licensees

Partnerships and licensing are a key part of REGENXBIO’s commitment to enabling the ongoing development of gene therapy treatments using our NAV Technology Platform. Our NAV Technology is being applied in the development of over 20 partnered product candidates for a variety of diseases by our NAV Technology Licensees.

to discuss partnering or licensing opportunities.

RGXB Logo large

Abeona

audentes Therapeutics

esteve

lysogene

NOVARTIS

Pfizer

PREVAIL THERAPEUTICS

rocket

takeda

Ultragenyx